Edition:
India

Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

5,915JPY
17 Oct 2017
Change (% chg)

¥42 (+0.72%)
Prev Close
¥5,873
Open
¥5,892
Day's High
¥5,918
Day's Low
¥5,858
Volume
663,200
Avg. Vol
698,606
52-wk High
¥7,280
52-wk Low
¥5,496

Summary

Name Age Since Current Position

Haruo Naito

69 2014 Chief Executive Officer, Representative Executive Officer, Director

Ryohei Yanagi

55 2015 Managing Executive Officer, Chief Financial Officer, Chief IR Officer

Hideki Hayashi

59 2016 Representative Executive Officer, Chief Information Officer

Junichi Asatani

56 2014 Chief Compliance Officer, Executive Officer

Kenta Takahashi

57 2016 General Counsel, Managing Executive Officer, President of Subsidiary

Ivan Cheung

40 2016 Managing Executive Officer, President of Neurology Business Group, President of America Region, Chairman & Chief Executive Officer of Subsidiary

Edward Geary

54 2013 Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs

Gary Hendler

50 2016 Managing Executive Officer, President of EMEA Region, Chief Commercial Officer of Oncology Business Group, President & Chief Executive Officer of Subsidiary

Terushige Iike

53 2016 Managing Executive Officer, President of Oncology Business Group

Masatomi Akana

50 2017 Executive Officer

Yanhui Feng

45 2016 Executive Officer, General Manager of Subsidiaries

Yasunobu Kai

55 2017 Executive Officer, Chief Planning Officer of Oncology Business Group, Director of Planning of Oncology Business Group

Shohei Kanazawa

52 2017 Executive Officer, President of Consumer hhc Business Unit

Hiroyuki Kato

59 2017 Executive Officer, Manager of Medicine Development Center

Yoshiteru Kato

57 2017 Executive Officer, President of Eisai Demand Chain Systems

Teiji Kimura

54 2016 Executive Officer, Chief Discovery Officer of Neurology Business Group, Director of Neurology Tsukuba Research Institute

Hiroyuki Kobayashi

43 2017 Executive Officer, Chief Medical Officer of Japan & Asia, Chief Director of Medical, Director of Neurology Medical Department

Lynn Kramer

66 2016 Executive Officer, Chief Clinical Officer of Neurology Business Group, Chief Medical Officer of Neurology Business Group

Masayuki Miyajima

55 2016 Executive Officer, President of Eisai Japan

Takashi Ohwa

54 2016 Executive Officer, Chief Medicine Creation Officer of Oncology Business Group, Chief Discovery Officer of Oncology Business Group

Shaji Procida

46 2014 Executive Officer, President of Subsidiary

Sayoko Sasaki

48 2017 Executive Officer, President of Asia Region

Alexander Scott

52 2016 Executive Officer, Chief Strategy Officer in Neurology Business Group, Director of Strategy in Neurology Business Group

Mitsuaki Tanaka

55 2017 Executive Officer, Chief Strategy Officer

Hidenori Yabune

47 2017 Executive Officer, Chief Director of Regional Cooperation Metropolitan Area of Eisai Japan

Tatsuyuki Yasuno

49 2017 Executive Officer, Chief Planning Officer, Director of Corporate Planning

Yasushi Okada

58 2017 Representative Executive Officer, Chief Talent Officer

Hirokazu Kanai

57 2016 Director

Noboru Naoe

61 2014 Director

Yutaka Tsuchiya

65 2017 Director

Bruce Aronson

65 2017 Independent Director

Tamaki Kakizaki

56 2016 Independent Director

Yasuhiko Kato

70 2016 Independent Director

Ikuo Nishikawa

66 2014 Independent Director

Eiichiro Suhara

69 2015 Independent Director

Daiken Tsunoda

50 2016 Independent Director

Toru Yamashita

69 2014 Independent Director

Shinya Watanabe

2016 Director of Accounting in Main Finance & Accounting Unit

Biographies

Name Description

Haruo Naito

Mr. Haruo Naito has been serving as Chief Executive Officer, Representative Executive Officer and Director in Eisai Co., Ltd. since June 2014. He is also working for The Naito Foundation. He joined the Company in October 1975. His previous titles include Director of Research and Development Promotion, Chief Director of Research and Development, Managing Director, Senior Managing Director, Vice President and President in the Company.

Ryohei Yanagi

Mr. Ryohei Yanagi has been serving as Managing Executive Officer, Chief Financial Officer and Chief IR Officer in Eisai Co., Ltd. since June 2015. He joined the Company in September 2009. His previous titles include Executive Officer and Director of Investor Relations(IR) in the Company.

Hideki Hayashi

Mr. Hideki Hayashi has been serving as Representative Executive Officer and Chief Information Officer in Eisai Co., Ltd. since April 2016. He joined the Company in April 1981. His previous titles include Vice President, Senior Managing Executive Officer, Executive Officer, Managing Executive Officer and Director of Business Development in the Company.

Junichi Asatani

Mr. Junichi Asatani has been serving as Chief Compliance Officer and Executive Officer in Eisai Co., Ltd. since June 2014. He joined the Company in April 1985. His previous titles include Director of Compliance & Risk Management Promotion and Director of Corporate IA in the Company.

Kenta Takahashi

Mr. Kenta Takahashi has been serving as General Counsel and Managing Executive Officer in Eisai Co., Ltd., as well as President and Representative Director of a subsidiary, since April 2016. He joined the Company in April 1983. His previous titles include Executive Officer and Director of Legal Affairs in the Company.

Ivan Cheung

Mr. Ivan Cheung has been serving as Managing Executive Officer, President of Neurology Business Group and President of America Region in Eisai Co., Ltd., as well as Chairman of the Board and Chief Executive Officer of a subsidiary, Eisai Inc., since April 2016. He joined the Company in October 2005. His previous titles include Executive Officer, Director of Promotion in Main Product Creation Unit in CEO's Office, Deputy Chief Director of Human Resources Development and Director of Talent Management and Director of Business Strategy in the Company.

Edward Geary

Mr. Edward Stewart Geary has been serving as Managing Executive Officer, Chief Medical Officer and Chief Director of Corporate Medical Affairs in Eisai Co., Ltd. since June 2013. He joined the Company in April 1997. His previous titles include Director of Pharmaceutical Business Policy, Executive Officer and Deputy Chief Director of Reliability Assurance in the Company. He used to work for Stanford University before joining the Company.

Gary Hendler

Mr. Gary Hendler has been serving as Managing Executive Officer, President of EMEA Region and Chief Commercial Officer of Oncology Business Group in Eisai Co., Ltd., as well as President and Chief Executive Officer of a subsidiary, Eisai Europe Ltd., since April 2016. He used to work for another subsidiary.

Terushige Iike

Mr. Terushige Iike has been serving as Managing Executive Officer and President of Oncology Business Group in Eisai Co., Ltd., since April 2016. He joined the Company in April 1986. His previous titles include Executive Officer, Director of Corporate Strategy and Director of Clinical Development in the Company.

Masatomi Akana

Mr. Masatomi Akana has been serving as Executive Officer in Eisai Co., Ltd. since June 2017. He joined the Company in April 1990. He previously served as Manager of Secretary Office in the Company.

Yanhui Feng

Yanhui Feng has been serving as Executive Officer in Eisai Co., Ltd., as well as General Manager of two China-based subsidiaries, including Eisai China Holdings Ltd. and Eisai China Inc., since April 2016. Feng used to work for another company.

Yasunobu Kai

Mr. Yasunobu Kai has been serving as Executive Officer, Chief Planning Officer of Oncology Business Group and Director of Planning of Oncology Business Group in Eisai Co., Ltd. since May 2017. He joined the Company in April 1986. His previous titles include President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems in the Company.

Shohei Kanazawa

Mr. Shohei Kanazawa has been serving as Executive Officer and President of Consumer hhc Business Unit in Eisai Co., Ltd. since June 2017. He joined the Company in April 1986. He previously served as President of Pharmaceutical Cosmetics Business Unit in the Company.

Hiroyuki Kato

Mr. Hiroyuki Kato has been serving as Executive Officer and Manager of Medicine Development Center in Eisai Co., Ltd. since June 2017. He joined the Company in April 1982.

Yoshiteru Kato

Mr. Yoshiteru Kato has been serving as Executive Officer and President of Eisai Demand Chain Systems in Eisai Co., Ltd. since June 2017. He joined the Company in April 1988.

Teiji Kimura

Mr. Teiji Kimura has been serving as Executive Officer, Chief Discovery Officer of Neurology Business Group and Director of Neurology Tsukuba Research Institute in Eisai Co., Ltd. since April 2016. He joined the Company in April 1987.

Hiroyuki Kobayashi

Mr. Hiroyuki Kobayashi has been serving as Executive Officer, Chief Medical Officer of Japan & Asia, Chief Director of Medical and Director of Neurology Medical Department in Eisai Co., Ltd. since June 2017. He joined the Company in January 2016. He previously served as Director of Oncology Medical in the Company. He used to work for Otsuka Pharmaceutical Co., Ltd.

Lynn Kramer

Mr. Lynn Kramer has been serving as Executive Officer, Chief Clinical Officer of Neurology Business Group and Chief Medical Officer of Neurology Business Group in Eisai Co., Ltd. since April 2016. He used to work for a subsidiary, Eisai Inc.

Masayuki Miyajima

Mr. Masayuki Miyajima has been serving as Executive Officer and President of Eisai Japan in Eisai Co., Ltd. since April 2016. He joined the Company in April 1985.

Takashi Ohwa

Mr. Takashi Ohwa has been serving as Executive Officer, Chief Medicine Creation Officer of Oncology Business Group and Chief Discovery Officer of Oncology Business Group in Eisai Co., Ltd. since April 2016. He joined the Company in April 1991. His previous titles include Director of 2nd Drug Development Research Institute and President of Oncology Drug Development Unit in the Company.

Shaji Procida

Ms. Shaji Procida has been serving as Executive Officer in Eisai Co., Ltd., as well as President and Chief Operating Officer of a subsidiary, Eisai Inc., since June 2014. She used to work for another company.

Sayoko Sasaki

Ms. Sayoko Sasaki has been serving as Executive Officer and President of Asia Region in Eisai Co., Ltd. since June 2017. She joined the Company in April 1991. Her previous titles include Manager of Global Access Strategy Office, Director of PR and Director of Government Relations in the Company.

Alexander Scott

Mr. Alexander Scott has been serving as Executive Officer, Chief Strategy Officer in Neurology Business Group and Director of Strategy in Neurology Business Group in Eisai Co., Ltd. since April 2016. He used to work for a subsidiary, Eisai Inc.

Mitsuaki Tanaka

Mr. Mitsuaki Tanaka has been serving as Executive Officer and Chief Strategy Officer in Eisai Co., Ltd. since June 2017. He joined the Company in April 1986. He previously served as Director of General Affairs & Environment Safety in the Company.

Hidenori Yabune

Mr. Hidenori Yabune has been serving as Executive Officer and Chief Director of Regional Cooperation Metropolitan Area in Eisai Japan of Eisai Japan in Eisai Co., Ltd. since April 2017. He joined the Company in April 1994.

Tatsuyuki Yasuno

Mr. Tatsuyuki Yasuno has been serving as Executive Officer, Chief Planning Officer and Director of Corporate Planning in Eisai Co., Ltd. since May 2017. He joined the Company in April 1991. He previously served as Director of Corporate Planning & Strategy in the Company.

Yasushi Okada

Mr. Yasushi Okada has been serving as Representative Executive Officer and Chief Talent Officer in Eisai Co., Ltd. since June 2017. He is also working for a fund. He joined the Company in April 1981. His previous titles include Director of Business Planning, Director of Business Promotion in Pharmaceutical Business Unit, Director of Business Strategy in Pharmaceutical Business Unit, Managing Executive Officer, Senior Managing Executive Officer and Director of Planning in Main Japan Business Main Unit in the Company.

Hirokazu Kanai

Mr. Hirokazu Kanai has been serving as Director in Eisai Co., Ltd. since June 2016. He is also a member of Audit Committee of the Company. He joined the Company in April 1983. His previous titles include Executive Officer, Director of Accounting and Director of Finance & Accounting in the Company.

Noboru Naoe

Mr. Noboru Naoe has been serving as Director in Eisai Co., Ltd. since June 2014. He is also a member of Audit Committee of the Company. He joined the Company in April 1978. His previous titles include Executive Officer, Deputy Director of Pharmaceutical Business, Director of Medicine Business, Senior Director of Medicine in Main Japan Business Unit, Managing Executive Officer and President of Eisai Japan in the Company.

Yutaka Tsuchiya

Mr. Yutaka Tsuchiya has been serving as Director in Eisai Co., Ltd. since June 2017. He joined the Company in April 1975. His previous titles include Executive Officer, Director of Planning in Clinical Test Research Center, Managing Executive Officer, Representative Executive Officer, Senior Managing Executive Officer and Chief Director of Reliability Assurance in the Company. He used to serve as Chairman of the Board and Chief Executive Officer in an United Kingdom-based subsidiary.

Bruce Aronson

Mr. Bruce Aronson has been serving as Independent Director in Eisai Co., Ltd. since June 2017. He is also a member of Nominating Committee and Compensation Committee of the Company. He is also a Designated Professor of Hitotsubashi University. He used to work for Nagashima Ohno & Tsunematsu, The University of Tokyo, Creighton University, Institute for Monetary and Economic Studies of Bank of Japan and other two law firms.

Tamaki Kakizaki

Ms. Tamaki Kakizaki has been serving as Independent Director in Eisai Co., Ltd. since June 2016. She is also a member of Audit Committee of the Company. She is also serving as Independent Director in Mitsubishi Shokuhin Co., Ltd. She is also a Professor of Meiji University. She used to work for Atomi University, Toyo University and Yokohama National University.

Yasuhiko Kato

Mr. Yasuhiko Kato has been serving as Independent Director in Eisai Co., Ltd. since June 2016. He is also Chairman of Compensation, and a member of Nomination Committee of the Company. He is also serving as Director in Mitsui Engineering & Shipbuilding Co., Ltd. He used to work for Mitsui Babcock Energy Limited.

Ikuo Nishikawa

Mr. Ikuo Nishikawa has been serving as Independent Director in Eisai Co., Ltd. since June 2014. He is also Chairman of Audit Committee of the Company. He is also serving as Independent Director in Daiwa Securities Group Inc. and Megmilk Snow Brand Company, Limited, and working for Mitsubishi Corporation. He is also a Guest Professor of Keio University, He used to work for Ernst & Young ShinNihon LLC, International Accounting Standards Committee, The Japanese Institute of Certified Public Accountants, Accounting Standards Board of Japan and Nidec Corporation.

Eiichiro Suhara

Mr. Eiichiro Suhara has been serving as Independent Director in Eisai Co., Ltd. since June 2015. He is also Chairman of Nomination Committee, and a member of Compensation Committee of the Company. He is also serving as Independent Director in YOKOHAMA SHINKO Co., Ltd. as well as President and Representative Director in MITSUBISHI PENCIL CO., LTD.

Daiken Tsunoda

Mr. Daiken Tsunoda has been serving as Independent Director in Eisai Co., Ltd. since June 2016. He is also a member of Audit Committee of the Company. He is also serving as Independent Director in MS&AD Insurance Group Holdings, Inc. and Culture Convenience Club Co., Ltd., as well as Partner in Nakamura, Tsunoda & Matsumoto, and working for SLEEP SELECT Co., Ltd. and BILCOM, Inc.

Toru Yamashita

Mr. Toru Yamashita has been serving as Independent Director in Eisai Co., Ltd. since June 2014. He is also serving as Independent Director in Mitsui Fudosan Co., Ltd. and Sumitomo Life Insurance Company, and working for NTT DATA CORPORATION and Cabinet Office, Japan. He used to work for Nippon Telegraph and Telephone Public Corporation.

Shinya Watanabe